
Latest News


On 20 February 2025, Aram Swinkels successfully defended his PhD from Utrecht University.



On 16 October, in the ‘Science Café’ at the RIVM, filled with eager scientists and researchers, a series early career research pitches were about to unfold. Each presenter had their unique story to tell, showcasing their innovative approaches to tackling some of the world’s most pressing research questions. At the end of the café the audience voted that Laura Derks of RIVM had won the NCOH Best Pitch Award.


On 16 October One Health enthusiasts gathered at the RIVM where Arjan van de Giessen of the opened the environmental Science Café, emphasizing the importance of addressing zoonotic diseases.
NCOH Student Travel Grant
The NCOH awards a number of travel grants to PhD students of NCOH Partners selected to present their abstract at an international One Health-related academic conference.


On 7 December 2022 Alexander Bakker successfully defended his thesis ‘Discovery of antibiotics and their targets in multidrug-resistant bacteria’ at Leiden University.


On 1 July 2022, the University of Groningen (UG) joined the Netherlands Center for One Health (NCOH) as a new Partner. Bert Poolman, professor Biochemistry at the Faculty of Science and Engineering: ‘Researchers from the University of Groningen contributing to NCOH cover a range of scientific disciplines, from biology, chemistry, pharmaceutical science to medicine’.


The gut microbiome forms a reservoir for opportunistic pathogens as well as for antimicrobial resistance genes. This finding is important because it offers a deeper insight in the dynamics and mechanism of antimicrobial resistance development. This project – supported by a grant from the Netherlands Centre for One Health – was performed by Paul Stege who defended his PhD thesis on November 9, 2022 at Utrecht University.


The National Reference Laboratory on Antimicrobial Resistance of Wageningen Bioveterinary Research (WBVR) in close cooperation with Wageningen Food Safety Research (WFSR) started whole genome sequencing (WGS) of all ESBL/AmpC-producing E. coli isolates to replace phenotypic antimicrobial susceptibility testing and additional PCR testing.